tradingkey.logo

GeneDx Holdings Corp

WGS
View Detailed Chart

79.710USD

+12.710+18.97%
Close 06/23, 16:00ETQuotes delayed by 15 min
2.27BMarket Cap
LossP/E TTM

GeneDx Holdings Corp

79.710

+12.710+18.97%
Intraday
1m
30m
1h
D
W
M
D

Today

+18.97%

5 Days

+19.17%

1 Month

+11.33%

6 Months

+4.33%

Year to Date

+3.71%

1 Year

+190.28%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 6 analysts
BUY
Current Rating
95.000
Target Price
41.79%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

68
Total
7
Median
8
Average
Company name
Ratings
Analysts
GeneDx Holdings Corp
WGS
6
CVS Health Corp
CVS
29
Teladoc Health Inc
TDOC
26
HCA Healthcare Inc
HCA
26
Tenet Healthcare Corp
THC
23
Universal Health Services Inc
UHS
21
1
2
3
...
14

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Buy
Sell(4)
Neutral(2)
Buy(7)
Indicators
Sell(3)
Neutral(2)
Buy(2)
Indicators
Value
Direction
MACD(12,26,9)
-0.095
Sell
RSI(14)
45.374
Neutral
STOCH(KDJ)(9,3,3)
30.574
Buy
ATR(14)
3.895
Low Volatility
CCI(14)
-66.769
Neutral
Williams %R
62.811
Sell
TRIX(12,20)
-0.322
Sell
StochRSI(14)
100.000
Buy
Moving Average
Sell(1)
Neutral(0)
Buy(5)
Indicators
Value
Direction
MA5
65.385
Buy
MA10
67.761
Buy
MA20
69.313
Buy
MA50
76.683
Buy
MA100
82.593
Sell
MA200
73.758
Buy

News

More news coming soon, stay tuned...

Company

GeneDx Holdings Corp. is a genomics company. The Company operates, through its subsidiary, GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It operates through GeneDx segment, which primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Exome sequencing test options include XomeDx, XomeDx Plus, and XomeDxXpress. GeneDx genome sequencing evaluates the protein-coding and non-coding regions of an individual’s nuclear genome. GeneDx genome sequencing test options include GenomeSeqDx and GenomeXpress. It offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. Its subsidiary, Fabric Genomics, Inc., specializes in artificial intelligence-powered genomic interpretation.
Ticker SymbolWGS
CompanyGeneDx Holdings Corp
CEOMs. Katherine A. Stueland
Websitehttps://sema4.com/
KeyAI